Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Straniuson Jun 28, 2017 12:41pm
398 Views
Post# 26414468

Updated Cap Structure & List of Participants After PP Close

Updated Cap Structure & List of Participants After PP CloseOk as promised, below is an updated cap structure after yesterday's PP close announcement. Keep in mind this does not include any June warrant exercise transactions that we won't know about until the company files it's June monthly report no later than the 5th trading day of July.

https://investorshub.advfn.com/uimage/uploads/2017/6/28/lppxo2017-06-27_LDS_Cap_Struct.jpg

User image

Incidentally, Form 9 which lists the participants in this most recent PP was also released and is available here:

https://thecse.com/sites/default/files/CSE_Form_9_Non-Brokered_PP_Close_Signed.pdf

@artfuldodger, the fully realized shares outstanding figure you referenced in your earlier post of 135 million is probably coming from my May 16 post here. That post included a catalyst table that went out to Dec 2017 and assumed LDS issued share (and cash) payments to NHMC, CSPA as well as the CEO's of LDS Agrotech and LDS Scientific based on the May 4 press release here. I consider that table to be somewhat dated based on newer information that has come to light since that post. I've been waiting for the COO issuance to rework that table and update the list of catalysts. They are all intertwined and triggered off the receipt of the COO and the Business License.

As of right now, there are ~85.1M shares outstanding and fully diluted share count is ~117.5M. Upcoming payments to NHMC, CSPA as well as the CEO's of LDS Agrotech and LDS Scientific over the next month (recall that July 31, 2017 is a trigger point) will increase these numbers but we will be one step closer to owning 100% of cash generating ability of the LDS conglomerate.

~S
Bullboard Posts